Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
6.64
-0.36 (-5.14%)
At close: Apr 28, 2026, 4:00 PM EDT
6.49
-0.15 (-2.26%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Tevogen Bio Holdings Market Cap
Tevogen Bio Holdings has a market cap or net worth of $27.65 million as of April 28, 2026. Its market cap has decreased by -84.96% in one year.
Market Cap
27.65M
Enterprise Value
33.97M
1-Year Change
-84.96%
Ranking
Category
Stock Price
$6.64
Market Cap Chart
Since January 5, 2022, Tevogen Bio Holdings's market cap has decreased from $446.69M to $27.65M, a decrease of -93.81%. That is a compound annual growth rate of -47.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 29.15M | -55.69% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celularity | 29.99M |
| Polyrizon | 29.85M |
| Tvardi Therapeutics | 29.69M |
| Dyadic International | 29.53M |
| BriaCell Therapeutics | 29.18M |
| Lisata Therapeutics | 29.08M |
| Outlook Therapeutics | 29.08M |
| Kyntra Bio | 28.53M |